Blood Disorder News and Research

RSS
Longer donor leukocyte telomere length linked to improved survival following HCT

Longer donor leukocyte telomere length linked to improved survival following HCT

Spark Therapeutics, Pfizer partner to develop SPK-FIX for potential treatment of hemophilia B

Spark Therapeutics, Pfizer partner to develop SPK-FIX for potential treatment of hemophilia B

Emerging strategies to boost healthy RBCs may reduce burden of anemia linked to blood disorders

Emerging strategies to boost healthy RBCs may reduce burden of anemia linked to blood disorders

Penn Medicine-developed drug gets FDA orphan status for PNH treatment

Penn Medicine-developed drug gets FDA orphan status for PNH treatment

Molecular diagnostics and blood screening systems: an interview with Dr Bos and Dr Koppelman

Molecular diagnostics and blood screening systems: an interview with Dr Bos and Dr Koppelman

Research performed in anemic mice shows acetate stimulates the formation of red blood cells

Research performed in anemic mice shows acetate stimulates the formation of red blood cells

Scientists identify gene mutation that causes aplastic anemia

Scientists identify gene mutation that causes aplastic anemia

Simple point-of-care testing device provides more rapid diagnosis of anemia

Simple point-of-care testing device provides more rapid diagnosis of anemia

Penn receives orphan status in Europe for treatment of PNH

Penn receives orphan status in Europe for treatment of PNH

FDA-approved drug eliminates immune cells that destroys hair follicles in people with alopecia areata

FDA-approved drug eliminates immune cells that destroys hair follicles in people with alopecia areata

Baxter International acquires drug candidate developed to treat sickle cell disease

Baxter International acquires drug candidate developed to treat sickle cell disease

Research explores links between planet's health and human health

Research explores links between planet's health and human health

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Provepharm, DFKC partner to launch Methylthioninium chloride Proveblue in Germany

Provepharm, DFKC partner to launch Methylthioninium chloride Proveblue in Germany

Findings could lead to treatments for blood disorders associated with iron deficiencies and overloads

Findings could lead to treatments for blood disorders associated with iron deficiencies and overloads

FDA approves Alexion’s Soliris drug for treatment of atypical hemolytic uremic syndrome

FDA approves Alexion’s Soliris drug for treatment of atypical hemolytic uremic syndrome

Alexion Pharmaceuticals obtains orphan drug designation from EC for Soliris

Alexion Pharmaceuticals obtains orphan drug designation from EC for Soliris

Penn research team discovers new cost-effective way to fight rare blood disorder

Penn research team discovers new cost-effective way to fight rare blood disorder

Penn researchers identify possible new way to fight rare blood disorder

Penn researchers identify possible new way to fight rare blood disorder

Blood disorder medicines could be used for treating stomach and bowel cancer

Blood disorder medicines could be used for treating stomach and bowel cancer